We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Noninvasive Diagnostic Panel for Liver Fibrosis

By HospiMedica staff writers
Posted on 02 Feb 2004
A simple blood test is designed to aid in the detection of liver fibrosis in patients with chronic hepatitis C and help doctors differentiate the degree of fibrosis without a liver biopsy.

FibroSpect II, an enhanced version of the original test, eliminates indeterminate test results occasionally reported with the first-generation test and improves the ability to differentiate patients with and without significant liver fibrosis. More...
The test is based on three extracellular matrix remodeling proteins utilizing a new algorithm and unique index, thereby providing doctors with more clinically useful information. FibroSpect II is the product of Prometheus Laboratories, Inc. (San Diego, CA, USA), a specialty pharmaceutical company.

"In chronic hepatitis C infection, liver biopsy has been the favored approach to evaluate the extent of liver fibrosis and help guide treatment decisions; however, it is expensive, associated with possible complications, and limited by sampling error and observer variability,” said Dr. F. Fred Poordad, associate director, hepatology and liver transplants at Cedars Sinai Medical Center (Los Angeles, CA, USA). "Noninvasive methods to aid in assessing liver disease severity, such as FibroSpect II, provide additional diagnostic options.”





Related Links:
Promethues Labs

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.